Values First Advisors Inc. Buys 18,184 Shares of Simulations Plus, Inc. $SLP

Values First Advisors Inc. grew its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 46.4% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 57,372 shares of the technology company’s stock after acquiring an additional 18,184 shares during the period. Values First Advisors Inc.’s holdings in Simulations Plus were worth $1,001,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Russell Investments Group Ltd. lifted its holdings in shares of Simulations Plus by 24.9% during the first quarter. Russell Investments Group Ltd. now owns 223,832 shares of the technology company’s stock worth $5,488,000 after purchasing an additional 44,601 shares during the period. Comerica Bank lifted its holdings in shares of Simulations Plus by 16.6% during the first quarter. Comerica Bank now owns 193,990 shares of the technology company’s stock worth $4,757,000 after purchasing an additional 27,579 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Simulations Plus by 16.2% during the first quarter. Charles Schwab Investment Management Inc. now owns 166,392 shares of the technology company’s stock worth $4,080,000 after purchasing an additional 23,139 shares during the period. Kopion Asset Management LLC lifted its holdings in Simulations Plus by 22.7% in the second quarter. Kopion Asset Management LLC now owns 156,401 shares of the technology company’s stock valued at $2,729,000 after buying an additional 28,980 shares during the period. Finally, Uniplan Investment Counsel Inc. lifted its holdings in Simulations Plus by 141.8% in the first quarter. Uniplan Investment Counsel Inc. now owns 144,202 shares of the technology company’s stock valued at $3,536,000 after buying an additional 84,562 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Price Performance

NASDAQ SLP opened at $16.02 on Friday. The stock has a market capitalization of $322.48 million, a PE ratio of -5.09 and a beta of 0.99. Simulations Plus, Inc. has a 1 year low of $12.39 and a 1 year high of $37.67. The company’s 50 day simple moving average is $14.80 and its two-hundred day simple moving average is $20.86.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Monday, July 14th. The technology company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.19. Simulations Plus had a positive return on equity of 11.62% and a negative net margin of 78.63%.The business had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. During the same period in the prior year, the company earned $0.27 EPS. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. KeyCorp lowered shares of Simulations Plus from an “overweight” rating to a “sector weight” rating in a report on Tuesday, July 15th. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Tuesday, July 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Simulations Plus in a research note on Wednesday, October 8th. Cowen assumed coverage on shares of Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating for the company. Finally, TD Cowen assumed coverage on shares of Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating and a $16.00 price target for the company. Four analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Simulations Plus has a consensus rating of “Hold” and a consensus price target of $24.40.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.